Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Personalized NK Cell Therapy in CBT
NCT02727803
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03816319
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States
NCT03128034
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03670966
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06372717
- Conditions
- Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +17 more
- Locations
-
- Monash Health Clayton, Victoria, Australia
- St. Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
- Hollywood Private Hospital Nedlands, Western Australia, Australia
NCT00801489
- Conditions
- Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
NCT03383575
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +22 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT00093470
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Kaiser Permanente-San Diego Mission San Diego, California, United States
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03096782
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, +34 more
- Locations
-
- Beebe Medical Center Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
- AdventHealth Orlando Orlando, Florida, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Active, Not Recruiting
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
NCT05600894
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UCI Health Laguna Hills Laguna Hills, California, United States
Active, Not Recruiting
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
NCT03399773
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Anemia, +29 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
NCT01522976
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +24 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
NCT00392353
- Conditions
- Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
- North Shore University Hospital Manhasset, New York, United States
- Mount Sinai Hospital New York, United States